These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 27369686)

  • 1. [Augmentation of Clozapine With Paliperidone in Schizophrenia Patients With Partial Response to Treatment: A Case Series].
    Kalenderoğlu A; Çelik M
    Turk Psikiyatri Derg; 2016; 27(1):57-62. PubMed ID: 27369686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study.
    Bioque M; Parellada E; García-Rizo C; Amoretti S; Fortea A; Oriolo G; Palau P; Boix-Quintana E; Safont G; Bernardo M
    Eur Psychiatry; 2020 Jul; 63(1):e71. PubMed ID: 32669145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching from clozapine to paliperidone palmitate-3-monthly improved obesity, hyperglycemia and dyslipidemia lowering antipsychotic dose equivalents in a treatment-resistant schizophrenia cohort.
    Martínez-Andrés JA; García-Carmona JA
    Int Clin Psychopharmacol; 2020 May; 35(3):163-169. PubMed ID: 31851035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thoughts on a favourable evolution of a COVID-19 in a patient with resistant schizophrenia and on a combination of clozapine and paliperidone palmitate].
    Bouaziz N; Ben Rejeb H; Ateb S; Fourati T; Chammas F; Baha D; Rosetti R; Kalalou K; Saba G; Benadhira R; Januel D
    Encephale; 2020 Jun; 46(3S):S126-S127. PubMed ID: 32475694
    [No Abstract]   [Full Text] [Related]  

  • 5. Paliperidone palmitate: effectiveness, safety, and the use for treatment of schizophrenia.
    Jarema M; Bieńkowski P; Heitzman J; Parnowski T; Rybakowski J
    Psychiatr Pol; 2017 Feb; 51(1):7-21. PubMed ID: 28455891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial.
    Josiassen RC; Joseph A; Kohegyi E; Stokes S; Dadvand M; Paing WW; Shaughnessy RA
    Am J Psychiatry; 2005 Jan; 162(1):130-6. PubMed ID: 15625211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Augmentation strategies in patients with schizophrenia who show partial response to clozapine treatment].
    Vayısoğlu S; Anıl Yağcıoğlu E
    Turk Psikiyatri Derg; 2014; 25(3):201-11. PubMed ID: 25219694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine augmentation with long-acting antipsychotic injections: A case series and systematic review.
    Oloyede E; Dima A; Taylor D; Cheung H; Dzahini O; Shergill S; Whiskey E
    Acta Psychiatr Scand; 2023 Dec; 148(6):538-552. PubMed ID: 37899506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual Atypical Antipsychotics in Treatment-Resistant Schizophrenia: A Correctional Case Report and Review of Literature.
    Warnick JA; Gifeisman RI; Joshi KP; Roe SA; Hiciano RA; Conroy CP; Zahedi S
    J Correct Health Care; 2024 Jun; 30(3):167-171. PubMed ID: 38563618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paliperidone for the treatment of schizophrenia and schizoaffective disorders - a drug safety evaluation.
    Mauri MC; Reggiori A; Paletta S; Di Pace C; Altamura AC
    Expert Opin Drug Saf; 2017 Mar; 16(3):365-379. PubMed ID: 28140680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promising use of minocycline augmentation with clozapine in treatment-resistant schizophrenia.
    Qurashi I; Collins JD; Chaudhry IB; Husain N
    J Psychopharmacol; 2014 Jul; 28(7):707-8. PubMed ID: 24646811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone augmentation for schizophrenia partially responsive to clozapine: a double-blind, placebo-controlled trial.
    Freudenreich O; Henderson DC; Walsh JP; Culhane MA; Goff DC
    Schizophr Res; 2007 May; 92(1-3):90-4. PubMed ID: 17321111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-glutamatergic clozapine augmentation strategies: a review and meta-analysis.
    Veerman SR; Schulte PF; Begemann MJ; de Haan L
    Pharmacopsychiatry; 2014 Nov; 47(7):231-8. PubMed ID: 25121994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined use of risperidone long-acting injection and clozapine in patients with schizophrenia non-adherent to clozapine: a case series.
    Se Hyun Kim ; Dong Chung Jung ; Yong Min Ahn ; Yong Sik Kim
    J Psychopharmacol; 2010 Jul; 24(7):981-6. PubMed ID: 19942641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paliperidone palmitate for refractory and clozapine-resistant schizophrenia.
    Maia-de-Oliveira JP; Nunes EA; Ushirohira JM; Machado-de-Sousa JP; Bressan RA; Hallak JE
    J Neuropsychiatry Clin Neurosci; 2015; 27(1):e14-6. PubMed ID: 25716490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation.
    Raskin S; Katz G; Zislin Z; Knobler HY; Durst R
    Acta Psychiatr Scand; 2000 Apr; 101(4):334-6. PubMed ID: 10782556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of paliperidone palmitate versus oral antipsychotics in patients with schizophrenia and a history of criminal justice involvement.
    Muser E; Kozma CM; Benson CJ; Mao L; Starr HL; Alphs L; Fastenau J
    J Med Econ; 2015; 18(8):637-45. PubMed ID: 25851616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalizing dosing of risperidone, paliperidone and clozapine using therapeutic drug monitoring and pharmacogenetics.
    de Leon J
    Neuropharmacology; 2020 May; 168():107656. PubMed ID: 31150659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine alone versus clozapine and risperidone with refractory schizophrenia.
    Honer WG; Thornton AE; Chen EY; Chan RC; Wong JO; Bergmann A; Falkai P; Pomarol-Clotet E; McKenna PJ; Stip E; Williams R; MacEwan GW; Wasan K; Procyshyn R;
    N Engl J Med; 2006 Feb; 354(5):472-82. PubMed ID: 16452559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does adding a second antipsychotic to clozapine improve clinical response in resistant schizophrenia?
    Jiménez-Cornejo M; Munizaga G; Aceituno D
    Medwave; 2016 Dec; 16(Suppl5):e6614. PubMed ID: 27922589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.